5-Nitrofluorescein

5-Nitrofluorescein

Pyraflufen

Pyraflufen

PSMA11

$300.00
CAS No.: 1366302-52-4
Catalog No.: WLZ0425
Purity: 95%
MF: C44H62N6O17
MW: 947.005
Storage: 2-8 degree Celsius
SMILES: C(=O)(O)CCC=1C=CC(=C(CN(CCN(CC(=O)O)CC=2C=C(C=CC2O)CCC(NCCCCCC(NCCCC[C@H](NC(N[C@@H](CCC(=O)O)C(=O)O)=O)C(=O)O)=O)=O)CC(=O)O)C1)O
Availability:
In stock
SKU
WLZ0425
  • Size
    Price
    Stock
    Estimated Shipping Time
CAS No.: 1366302-52-4; PSMA11. PROPERTIES: PSMA11 is a peptide-based targeting ligand with molecular weight approximately 1025.3 g/mol. It typically exists as hygroscopic white powder with critical sensitivity to moisture and oxygen. The compound shows optimal stability when stored at -80 C in vacuum-sealed ampules with desiccant packs. Its aqueous solubility is pH-dependent, reaching maximum around pH 7.4 at ~5 mg/mL. Safety protocols emphasize using powder-free nitrile gloves and working in certified biosafety cabinets due to its biological activity. APPLICATIONS: PSMA11 is predominantly utilized in prostate-specific membrane antigen (PSMA) targeted imaging and therapy. In nuclear medicine, it serves as a radiolabeled tracer for positron emission tomography (PET) imaging of prostate cancer, with European Journal of Nuclear Medicine and Molecular Imaging studies demonstrating high tumor-to-background ratios. For therapeutic applications, PSMA11 conjugated to radionuclides like lutetium-177 enables targeted radionuclide therapy, as detailed in Journal of Medicinal Chemistry preclinical reports. Additionally, the ligand finds use in developing multifunctional nanoparticles for PSMA-targeted drug delivery systems, with Biomaterials publications highlighting enhanced tumor accumulation and reduced off-target effects. Researchers also employ PSMA11 in studying PSMA expression patterns across different tissue types, with Cancer Research articles providing insights into its diagnostic utility beyond prostate cancer.

Reviews

Write Your Own Review
You're reviewing:PSMA11
Your Rating